Document is current

Article History

Received: 1 February 2024

Accepted: 6 January 2025

First Online: 24 February 2025

Declarations

:

: Informed consent was obtained from all participants. Prior to completing the questionnaire, participants were provided with an information letter outlining the study’s objectives and the survey’s purpose and content where the participants had to tick “I agree to participate” in order to continue to the survey. All participants were explicitly informed of their right to withdraw from the study at any point, without facing any adverse consequences. To ensure anonymity, the survey did not collect any personally identifiable information, such as names, birth dates, or residential addresses. Although the Norwegian Cancer Society (NCS) had the ability to link survey responses to basic panel participants’ information, the researchers did not have access to any identifiable data. The research was conducted in accordance with the Helsinki Declaration [] and adhered to the guidelines established by the NCS user panel. The study was sought approved by the Regional Committee for Medical Research Ethics Northern Norway (REK 272059) that stated that ”the project does not appear to be a medical and health research project that should be assessed by the REK (Regional Committees for Medical and Health Research Ethics) according to the Health Research Act.” As a result, approval from the Regional Committees for Medical and Health Research Ethics was not required. Instead, approval was sought and granted by the Norwegian Centre for Research Data (NSD) under reference number 660552.

: Not applicable.

: The authors declare no competing interests.